e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Diagnosis, staging, epidemiology, management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The importance of intrapleurally γ-interferon in ambulatory management of malignant pleural effusion in elderly patients with end-stage NSCCL
M. L. Ferdoutsis, G. D. Meletis, E. N. Thanou, F. N. Oikonomidou, K. Samara, K. Thymaki, G. M. Patsourakis, A. M. Kaltsounaki, N. Bachlitzanakis (Heraklion, Greece)
Source:
Annual Congress 2005 - Diagnosis, staging, epidemiology, management
Session:
Diagnosis, staging, epidemiology, management
Session type:
Poster Discussion
Number:
3246
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. L. Ferdoutsis, G. D. Meletis, E. N. Thanou, F. N. Oikonomidou, K. Samara, K. Thymaki, G. M. Patsourakis, A. M. Kaltsounaki, N. Bachlitzanakis (Heraklion, Greece). The importance of intrapleurally γ-interferon in ambulatory management of malignant pleural effusion in elderly patients with end-stage NSCCL. Eur Respir J 2005; 26: Suppl. 49, 3246
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Related content which might interest you:
Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003
Predictors of successful pleurodesis for patients with malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 493s
Year: 2004
Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Optimal management of symptomatic malignant pleural effusions: individualised care
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006
Mortality among patients with pleural effusion undergoing thoracentesis
Source: Eur Respir J 2015; 46: 495-502
Year: 2015
Ambulatory management of malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 629s
Year: 2004
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
Thoracoscopic palliative treatment of malignant pleural effusions
Source: Annual Congress 2011 - A little bit of everything: interventional pneumology
Year: 2011
Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021
Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006
Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007
Role of medical thoracoscopy in diagnosis of recurrent undiagnosed pleural effusion
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 542s
Year: 2003
Management of recurrent malignant pleural effusions
Source: ERS Skills Course 2016
Year: 2016
Management of recurrent malignant pleural effusions
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept